Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Ann Allergy Asthma Immunol. 2020 Feb;124(2):156-164. doi: 10.1016/j.anai.2019.11.022. Epub 2019 Nov 22.
This review provides an overview of the literature on hypersensitivity reactions during procedures to commonly used contrast agents and dyes. A synthesis of current knowledge on clinical symptoms, epidemiology and risk factors, pathomechanism, and management of hypersensitivity reactions to these substances is presented.
A literature search was conducted through Medline. Included were peer-reviewed articles written in English between 2000 and 2019.
Relevant clinical studies, experimental studies, and review articles have been selected. Additionally, case reports have been included if they carried significant information about rare clinical forms of hypersensitivity reactions, disease mechanisms, or therapy.
An allergological workup is only indicated for patients with a history of immediate (IHR) and nonimmediate hypersensitivity reactions (NIHR) but not for toxic or unrelated adverse events. Skin tests with or without experimental cellular laboratory tests in patients with previous reactions can provide evidence for an allergic mechanism. Positive skin tests indicating allergy are more common in severe reactions. If the adverse event was allergic, skin testing of alternatives is helpful for the selection of other contrast agents for future procedures. Premedication alone may be insufficient in these cases, and breakthrough reactions occur. For nonallergic reactions, change of contrast agent and premedication is often but not always sufficient to suppress reactions.
Patients with previous NIHR or IHR, especially moderate and severe IHR, needing potential re-administration of contrast agents should be skin tested to identify an allergic mechanism as well as alternative agents to be used for future procedures.
本文综述了常用对比剂和染料在介入操作过程中发生过敏反应的文献。本文综合了目前关于这些物质引起的过敏反应的临床症状、流行病学和危险因素、发病机制以及处理方法的知识。
通过 Medline 进行文献检索。纳入了 2000 年至 2019 年间发表的英文同行评议文章。
选择了相关的临床研究、实验研究和综述文章。此外,如果病例报告载有关于过敏反应罕见临床形式、疾病机制或治疗的重要信息,也将其纳入。
仅对有即刻(IHR)和非即刻(NIHR)过敏反应史的患者进行过敏检查,而对毒性或非相关不良事件则无需进行检查。对有既往反应的患者进行皮肤试验(伴有或不伴有实验细胞实验室检查)可提供过敏机制的证据。阳性皮肤试验提示过敏的情况在严重反应中更为常见。如果不良事件是过敏引起的,对替代药物进行皮肤试验有助于选择其他对比剂用于未来的操作。单独使用预用药在这些情况下可能不足,会出现突破性反应。对于非过敏反应,改变对比剂和预用药通常但并非总是足以抑制反应。
对于需要重新给予对比剂的既往有 NIHR 或 IHR 的患者,特别是有中度和重度 IHR 的患者,应进行皮肤试验以确定过敏机制,并确定用于未来操作的替代药物。